More articles from Letters to the Editor

You have access
In Reply: Familial hypercholesterolemia: Clarifications
Nishant P. Shah, MD,FACC, Haitham M. Ahmed, MD and W. H. Wilson Tang, MD

Cleveland Clinic Journal of Medicine June 2020, 87 (6) 320; DOI: https://doi.org/10.3949/ccjm.87c.06002

The authors' response.
You have access
Familial hypercholesterolemia: Clarifications
Taher Modarressi, MD

Cleveland Clinic Journal of Medicine June 2020, 87 (6) 320; DOI: https://doi.org/10.3949/ccjm.87c.06001

Comments on xanthoma vs xanthelasmas, and goal LDL-C.
You have access
In reply: Infective endocarditis: Don’t forget the ICE
Nkemdilim Mgbojikwe, MD, Steven R. Jones, MD, Thorsten M. Leucker, MD, PhD and Daniel J. Brotman, MD

Cleveland Clinic Journal of Medicine April 2020, 87 (4) 192; DOI: https://doi.org/10.3949/ccjm.87c.04002

Echocardiography relies on finding an anatomic abnormality, whereas 18FDG-PET is a functional examination.
You have access
Infective endocarditis: Don’t forget the ICE
Faris G. Araj, MD and Michael Luna, MD

Cleveland Clinic Journal of Medicine April 2020, 87 (4) 191; DOI: https://doi.org/10.3949/ccjm.87c.04001

A recent article did not mention intracardiac echocardiography.
You have access
Flu vaccine and gout attacks
Shih-Wei Lai, MD

Cleveland Clinic Journal of Medicine February 2020, 87 (2) 76; DOI: https://doi.org/10.3949/ccjm.87c.02003
You have access
In reply: Barrett esophagus: Definition, treatment
Tavankit Singh, MD, Vedha Sanghi, MD and Prashanthi N. Thota, MD, FACG

Cleveland Clinic Journal of Medicine February 2020, 87 (2) 75-76; DOI: https://doi.org/10.3949/ccjm.87c.02002
You have access
Barrett esophagus: Definition, treatment
Shih-Wei Lai, MD

Cleveland Clinic Journal of Medicine February 2020, 87 (2) 75; DOI: https://doi.org/10.3949/ccjm.87c.02001
You have access
In reply: How should diabetic dyslipidemia be treated?
Ting-I Lee, MD, PhD

Cleveland Clinic Journal of Medicine January 2020, 87 (1) 11; DOI: https://doi.org/10.3949/ccjm.87c.01004
You have access
In reply: Is diabetes still a compelling indication for renin-angiotensin-aldosterone system inhibitors?
Sunil Bhandari, MBChB, FRCP, PhD, M Clin Edu, FHEA, Tasnim Momoniat, MBChB, MRCP (UK) and Duha Ilyas, MBBS, MRCP (UK)

Cleveland Clinic Journal of Medicine January 2020, 87 (1) 9-10; DOI: https://doi.org/10.3949/ccjm.87c.01002
You have access
Is diabetes still a compelling indication for renin-angiotensin-aldosterone system inhibitors?
Robert Fakheri, MD, Sripal Bangalore, MD and Franz Messerli, MD

Cleveland Clinic Journal of Medicine January 2020, 87 (1) 9; DOI: https://doi.org/10.3949/ccjm.87c.01001

Main menu

User menu

Search

More articles from Letters to the Editor

Pages

Navigate

Info For

Other Resources